New York-based Balchem Corporation has signed a definitive agreement to acquire Norwegian Vitamin K2 supplier Kappa Bioscience AS for approximately US$340 million.
A scientist working for Kappa Bioscience discovered the secret of how to produce vitamin K on a large scale after noticing a growing demand for K2 due to its extraordinary health benefits.
Norwegian firm Kappa Bioscience is to form a "Blue Ribbon" Scientific and Medical Advisory Board made up of prominent scientists that will support and expand the knowledge base for vitamin K2.
